AU2001240793A1 - Novel assay - Google Patents

Novel assay

Info

Publication number
AU2001240793A1
AU2001240793A1 AU2001240793A AU4079301A AU2001240793A1 AU 2001240793 A1 AU2001240793 A1 AU 2001240793A1 AU 2001240793 A AU2001240793 A AU 2001240793A AU 4079301 A AU4079301 A AU 4079301A AU 2001240793 A1 AU2001240793 A1 AU 2001240793A1
Authority
AU
Australia
Prior art keywords
novel assay
assay
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001240793A
Inventor
Walter Blackstock
Richard Stephen Hale
Adele Rowley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2001240793A1 publication Critical patent/AU2001240793A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
AU2001240793A 2000-03-10 2001-03-09 Novel assay Abandoned AU2001240793A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0005895.8A GB0005895D0 (en) 2000-03-10 2000-03-10 Novel assay
GB0005895 2000-03-10
PCT/GB2001/001059 WO2001067097A2 (en) 2000-03-10 2001-03-09 Method of identifying modulators of presenilin

Publications (1)

Publication Number Publication Date
AU2001240793A1 true AU2001240793A1 (en) 2001-09-17

Family

ID=9887439

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001240793A Abandoned AU2001240793A1 (en) 2000-03-10 2001-03-09 Novel assay

Country Status (5)

Country Link
US (1) US20050101766A1 (en)
EP (1) EP1259822A2 (en)
AU (1) AU2001240793A1 (en)
GB (1) GB0005895D0 (en)
WO (1) WO2001067097A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0123379D0 (en) * 2001-09-28 2001-11-21 Lorantis Ltd Modulators
WO2005023858A1 (en) * 2003-09-05 2005-03-17 Cellzome Ag Protein complexes associated with app-processing
US8129334B2 (en) * 2006-03-31 2012-03-06 The Regents Of The University Of California Methods and compositions for treating neurodegenerative disorders and Alzheimer'S disease and improving normal memory
US7851228B2 (en) * 2006-03-31 2010-12-14 The Regents Of The University Of California Methods for screening agents that modulate presenilin activity and A-β production
CN110330559B (en) * 2019-06-06 2021-06-22 程张军 P120ctn protein mutant and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6383758B1 (en) * 1998-01-09 2002-05-07 The Governing Council Of The University Of Toronto Alzheimer's related proteins and methods of use

Also Published As

Publication number Publication date
US20050101766A1 (en) 2005-05-12
EP1259822A2 (en) 2002-11-27
WO2001067097A3 (en) 2002-05-16
GB0005895D0 (en) 2000-05-03
WO2001067097A2 (en) 2001-09-13

Similar Documents

Publication Publication Date Title
AU2002218331A1 (en) Bioanalytical assay
AU2002353861A1 (en) Assay
AU2002359392A1 (en) Rapid prion-detection assay
AU2001281965A1 (en) Novel 6-phenylphenanthridines
AU2001232132A1 (en) Novel assay
AU2001232041A1 (en) Improved assay
AU1531801A (en) Novel assay
AU2002221132A1 (en) Novel antibody
GB0012860D0 (en) Assay
AU2001240793A1 (en) Novel assay
AU7537400A (en) Assay
AU4670901A (en) Homocysteine assay
AU5240901A (en) Assay
AU2001268264A1 (en) Resazurin-based cytotoxicity assay
GB0005894D0 (en) Assay
GB0003902D0 (en) Assay
AUPQ943700A0 (en) Micronucleus assay
AU2002219846A1 (en) Novel use
AU2001276499A1 (en) Assay
AU3389501A (en) Assay
AU2001274750A1 (en) Novel beta-hydroxyamides
GB0025804D0 (en) Assay
GB0001703D0 (en) Assay
AU2001279721A1 (en) Structural member
GB0023239D0 (en) Assay